Methods and composition for inducing satiety
US-9216191-B2 · Dec 22, 2015 · US
US9820498B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9820498-B2 |
| Application number | US-201414771932-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 8, 2014 |
| Priority date | Apr 12, 2013 |
| Publication date | Nov 21, 2017 |
| Grant date | Nov 21, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An aqueous solution comprising (a) one or more mono-, di- and/or oligosaccharides and (b) a methylcellulose, wherein the methylcellulose has anhydroglucose units joined by 1-4 linkages wherein hydroxy groups of anhydroglucose units are substituted with methyl groups such that s23/s26 is 0.36 or less, is produced by i) mixing the methylcellulose with an aqueous liquid comprising one or more mono-, di- and/or oligosaccharides at a shear rate of at least 1000 s −1 or ii) mixing one or more mono-, di- and/or oligosaccharides with the methylcellulose and/or an aqueous liquid before, simultaneously with or after mixing the methylcellulose with the aqueous liquid at a shear rate of at least 1000 s −1 .
Opening claim text (preview).
The invention claimed is: 1. An aqueous solution comprising (a) one or more mono-, di- and/or oligosaccharides and (b) a methylcellulose, wherein the methylcellulose has anhydroglucose units joined by 1-4 linkages wherein hydroxy groups of anhydroglucose units are substituted with methyl groups such that s23/s26 is 0.36 or less, wherein s23 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 3-positions of the anhydroglucose unit are substituted with methyl groups and s26 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 6-positions of the anhydroglucose unit are substituted with methyl groups, wherein the concentration of the methylcellulose (MC) is from 0.2 to 2.5 percent and the aqueous solution has a gel fracture force F GF (37° C.) of i) at least 1.2 N and up to 20 N when the MC concentration is from 0.2 to 0.4 percent, ii) at least 1.5 N and up to 20 N when the MC concentration is from 0.5 to 0.7 percent, iii) at least 2.0 N and up to 20 N when the MC concentration is from 0.8 to 1.0 percent, iv) at least 3.0 N and up to 20 N when the MC concentration is from 1.1 to 1.3 percent, v) at least 4.5 N and up to 20 N when the MC concentration is from 1.4 to 1.6 percent, vi) at least 6.5 N and up to 75 N when the MC concentration is from 1.7 to 1.9 percent, vii) at least 8.5 N and up to 75 N when the MC concentration is from 2.0 to 2.2 percent, or viii) at least 12.0 N and up to 75 N when the MC concentration is from 2.3 to 2.5 percent, based on the total weight of the aqueous solution. 2. The aqueous solution of claim 1 wherein the concentration of the methylcellulose (MC) is from 0.8 to 2.2 percent and the aqueous solution has a gel fracture force F GF (37° C.) of at least 2.0 N and up to 20 N when the MC concentration is from 0.8 to 1.0 percent, at least 3.0 N and up to 20 N when the MC concentration is from 1.1 to 1.3 percent, at least 4.5 N and up to 20 N when the MC concentration is from 1.4 to 1.6 percent, at least 6.5 N and up to 75 N when the MC concentration is from 1.7 to 1.9 percent, or at least 8.5 N and up to 75 N when the MC concentration is from 2.0 to 2.2 percent, based on the total weight of the aqueous solution. 3. The aqueous solution of claim 1 wherein the concentration of the methylcellulose (MC) is from 0.8 to 2.2 percent and the aqueous solution has a gel fracture force F GF (37° C.) of at least 3.0 N and up to 20 N when the MC concentration is from 0.8 to 1.0 percent, at least 4.5 N and up to 20 N when the MC concentration is from 1.1 to 1.3 percent, at least 5.5 N and up to 20 N when the MC concentration is from 1.4 to 1.6 percent, at least 8.5 N and up to 75 N when the MC concentration is from 1.7 to 1.9 percent, or at least 10.0 N and up to 75 N when the MC concentration is from 2.0 to 2.2 percent, based on the total weight of the aqueous solution. 4. The aqueous solution of claim 1 wherein the aqueous solution has been prepared by i) mixing the methylcellulose with an aqueous liquid comprising one or more mono-, di- and/or oligosaccharides at a shear rate of at least 1000 s −1 , or ii) mixing one or more mono-, di- and/or oligosaccharides with the methylcellulose and/or an aqueous liquid before, simultaneously with or after mixing the methylcellulose with the aqueous liquid at a shear rate of at least 1000 s −1 . 5. The aqueous solution of claim 1 wherein the viscosity of the methylcellulose is from 200 to 10000 mPa·s, when measured as a 2 wt. % solution in water at 5° C. at a shear rate of 10 s −1 . 6. The aqueous solution of claim 1 comprising from 2.0 to 25 percent of one or more mono-, di- and/or oligosaccharides, based on the total weight of the solution. 7. A medicament, food, food ingredient or food supplement comprising or being made of the aqueous solution of claim 1 . 8. A method of reducing caloric intake, inducing satiety or reversibly reducing stomach void volume in an individual or of treating gastric ulcers, gastro-esophageal reflux disease, or obesity, or of aiding slimming, weight loss, or weight control in a non-obese individual, comprising the step of administering to said individual the medicament, food, food ingredient or food supplement of claim 7 . 9. The method of claim 8 , wherein the individual is not obese. 10. A method of reducing caloric intake, inducing satiety or reversibly reducing stomach void volume in an individual or of treating gastric ulcers, gastro-esophageal reflux disease, or obesity, or of aiding slimming, weight loss, or weight control in a non-obese individual, comprising the step of administering to said individual the aqueous solution of claim 1 . 11. The method of claim 10 , wherein the individual is not obese.
Anorexiants; Antiobesity agents · CPC title
Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence) · CPC title
Cellulose or derivatives thereof · CPC title
Celluloses · CPC title
Cellulose; Derivatives thereof, e.g. ethers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.